• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨桥蛋白通过激活 PI3k/Akt/mTOR 通路促进三阴性乳腺癌的肿瘤生长和转移以及 GPX4 介导的抗脂质过氧化。

Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k/Akt/mTOR pathway.

机构信息

Department of Thyroid and Breast Surgery, Nanyang Central Hospital, No. 312 Gongnong Road, Wancheng District, Nanyang City, 473005, Henan Province, China.

Xinxiang Medical University, Xinxiang City, 453003, Henan Province, China.

出版信息

J Cancer Res Clin Oncol. 2024 Mar 25;150(3):155. doi: 10.1007/s00432-024-05658-w.

DOI:10.1007/s00432-024-05658-w
PMID:38526702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10963528/
Abstract

PURPOSE

Triple-negative breast cancer (TNBC) features high aggressiveness, metastasis rate, drug resistance as well as poor prognosis. Osteopontin (OPN) is a key protein in the process of osteogenesis and has emerged as a new tumor marker in recent years.

METHODS

Cell viability was tested with the CCK-8 kit. Transwell and wound healing were adopted to test cell invasive and migratory abilities. Tumor sphere formation was detected by tumor sphere formation assay. Human umbilical vein endothelial cell (HUVEC) tube formation assay was used to measure the angiogenesis of tumor cells. Western blot was applied for the estimation of the expression of cancer stem cell markers, angiogenesis-, signaling pathway-related proteins as well as OPN. Bioinformatics tools predicted OPN expression in breast cancer tissues. The levels of oxidative stress-related markers were assessed with ELISA. Following the overexpression of OPN in MD-MB-436 cells and the addition of the PI3K/AKT/mTOR pathway inhibitor LY294002, the aforementioned functional experiments were implemented again to investigate the mechanism. Finally, in vivo experiments of tumor-bearing mice were performed for further verification.

RESULTS

The proliferative, invasive, migratory and tumor sphere formation capabilities as well as angiogenesis of TNBC cells were conspicuously increased in contrast to non-TNBC cell lines. OPN expression in TNBC tissues and cells was dramatically enhanced. OPN upregulation significantly elevated cell proliferative, invasive and migratory capabilities as well as tumor sphere formation and angiogenesis. The mechanism might be achieved by activating PI3K/AKT/mTOR signaling to regulate glutathione peroxidase 4 (GPX4)-mediated anti-lipid peroxidation.

CONCLUSION

OPN promoted tumor sphere formation and angiogenesis in TNBC by activating the PI3K/AKT/mTOR pathway to regulate GPX4-mediated anti-lipid peroxidation levels.

摘要

目的

三阴性乳腺癌(TNBC)具有侵袭性高、转移率高、耐药性强、预后差等特点。骨桥蛋白(OPN)是成骨过程中的关键蛋白,近年来已成为新的肿瘤标志物。

方法

用 CCK-8 试剂盒检测细胞活力。采用 Transwell 和划痕实验检测细胞侵袭和迁移能力。通过肿瘤球形成实验检测肿瘤球形成能力。用人脐静脉内皮细胞(HUVEC)管形成实验测量肿瘤细胞的血管生成能力。Western blot 用于评估癌症干细胞标志物、血管生成、信号通路相关蛋白和 OPN 的表达。生物信息学工具预测乳腺癌组织中 OPN 的表达。用 ELISA 评估氧化应激相关标志物的水平。在 MD-MB-436 细胞中转染 OPN 并添加 PI3K/AKT/mTOR 通路抑制剂 LY294002 后,再次进行上述功能实验,以探讨其机制。最后,进行荷瘤小鼠的体内实验进行进一步验证。

结果

与非 TNBC 细胞系相比,TNBC 细胞的增殖、侵袭、迁移和肿瘤球形成能力以及血管生成能力显著增强。TNBC 组织和细胞中的 OPN 表达明显上调。OPN 的上调显著提高了细胞的增殖、侵袭和迁移能力以及肿瘤球形成和血管生成能力。其机制可能是通过激活 PI3K/AKT/mTOR 信号通路来调节谷胱甘肽过氧化物酶 4(GPX4)介导的抗脂质过氧化。

结论

OPN 通过激活 PI3K/AKT/mTOR 通路调节 GPX4 介导的抗脂质过氧化水平,促进 TNBC 中的肿瘤球形成和血管生成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d3/10963528/e834340fab9f/432_2024_5658_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d3/10963528/66b3e51795f3/432_2024_5658_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d3/10963528/fbfdc12af7d1/432_2024_5658_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d3/10963528/cad390f4f22f/432_2024_5658_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d3/10963528/8d1eb6f9b0e1/432_2024_5658_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d3/10963528/6092f6e9797d/432_2024_5658_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d3/10963528/1d760e863343/432_2024_5658_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d3/10963528/e834340fab9f/432_2024_5658_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d3/10963528/66b3e51795f3/432_2024_5658_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d3/10963528/fbfdc12af7d1/432_2024_5658_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d3/10963528/cad390f4f22f/432_2024_5658_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d3/10963528/8d1eb6f9b0e1/432_2024_5658_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d3/10963528/6092f6e9797d/432_2024_5658_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d3/10963528/1d760e863343/432_2024_5658_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d3/10963528/e834340fab9f/432_2024_5658_Fig7_HTML.jpg

相似文献

1
Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k/Akt/mTOR pathway.骨桥蛋白通过激活 PI3k/Akt/mTOR 通路促进三阴性乳腺癌的肿瘤生长和转移以及 GPX4 介导的抗脂质过氧化。
J Cancer Res Clin Oncol. 2024 Mar 25;150(3):155. doi: 10.1007/s00432-024-05658-w.
2
Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway.染料木黄酮通过靶向 EGFR 介导的 PI3K/Akt/mTOR 通路抑制三阴性乳腺癌肺转移。
Sci China Life Sci. 2024 Sep;67(9):1849-1866. doi: 10.1007/s11427-023-2499-2. Epub 2024 Jun 17.
3
Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway.hsa-miR-570-3p 通过靶向 CD274 阻断 PI3K/AKT/mTOR 信号通路对三阴性乳腺癌的保护作用。
Kaohsiung J Med Sci. 2020 Aug;36(8):581-591. doi: 10.1002/kjm2.12212. Epub 2020 Apr 20.
4
Osteopontin knockdown inhibits αv,β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway.骨桥蛋白敲低通过诱导自噬和使PI3K/Akt/mTOR通路失活,抑制αv、β3整合素诱导的乳腺癌细胞迁移和侵袭,并促进其凋亡。
Cell Physiol Biochem. 2014;33(4):991-1002. doi: 10.1159/000358670. Epub 2014 Apr 1.
5
Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway.莪术根茎通过 PI3K/Akt/mTOR 通路抑制三阴性乳腺癌细胞的增殖、迁移、侵袭和转移。
J Ethnopharmacol. 2018 Jan 30;211:89-100. doi: 10.1016/j.jep.2017.09.033. Epub 2017 Sep 27.
6
Silence of α1-Antitrypsin Inhibits Migration and Proliferation of Triple Negative Breast Cancer Cells.α1-抗胰蛋白酶沉默抑制三阴性乳腺癌细胞的迁移和增殖。
Med Sci Monit. 2018 Sep 27;24:6851-6860. doi: 10.12659/MSM.910665.
7
TYMS Knockdown Suppresses Cells Proliferation, Promotes Ferroptosis via Inhibits PI3K/Akt/mTOR Signaling Pathway Activation in Triple Negative Breast Cancer.TYMS 敲低通过抑制三阴性乳腺癌中 PI3K/Akt/mTOR 信号通路的激活抑制细胞增殖,促进铁死亡。
Cell Biochem Biophys. 2024 Sep;82(3):2717-2726. doi: 10.1007/s12013-024-01388-5. Epub 2024 Jul 4.
8
Osteopontin Promotes Colorectal Cancer Cell Invasion and the Stem Cell-Like Properties through the PI3K-AKT-GSK/3β-β/Catenin Pathway.骨桥蛋白通过 PI3K-AKT-GSK/3β-β/Catenin 通路促进结直肠癌细胞侵袭和干细胞样特性。
Med Sci Monit. 2019 Apr 24;25:3014-3025. doi: 10.12659/MSM.913185.
9
ROR2 promotes invasion and chemoresistance of triple-negative breast cancer cells by activating PI3K/AKT/mTOR signaling.ROR2 通过激活 PI3K/AKT/mTOR 信号促进三阴性乳腺癌细胞的侵袭和化疗耐药性。
Oncol Res. 2024 Jun 20;32(7):1209-1219. doi: 10.32604/or.2024.045433. eCollection 2024.
10
Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling.Hsa_circ_0000199 通过干扰 miR-206/613 介导的 PI3K/Akt/mTOR 信号通路促进三阴性乳腺癌的化疗耐受。
Aging (Albany NY). 2021 Jan 20;13(3):4522-4551. doi: 10.18632/aging.202415.

引用本文的文献

1
The Effect of CDKN1A on the Expression of Genes Related to Milk Protein and Milk Fat Synthesis in Bovine Mammary Epithelial Cells.CDKN1A对牛乳腺上皮细胞中乳蛋白和乳脂肪合成相关基因表达的影响
Vet Sci. 2025 Jun 1;12(6):534. doi: 10.3390/vetsci12060534.
2
Treatment strategies targeting the phosphoinositide 3-kinase/protein kinase B/mechanistic target of rapamycin pathway against triple-negative breast cancer.针对磷酸肌醇3激酶/蛋白激酶B/雷帕霉素作用机制靶点通路治疗三阴性乳腺癌的策略
World J Clin Oncol. 2025 May 24;16(5):104623. doi: 10.5306/wjco.v16.i5.104623.
3
Ability of SPP1 to Alleviate Post-Intracerebral Hemorrhage Ferroptosis via Nrf2/HO1 Pathway.

本文引用的文献

1
Ferroptosis: the emerging player in remodeling triple-negative breast cancer.铁死亡:重塑三阴性乳腺癌的新兴角色。
Front Immunol. 2023 Oct 20;14:1284057. doi: 10.3389/fimmu.2023.1284057. eCollection 2023.
2
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.PI3K/AKT/mTOR 信号转导通路与癌症的靶向治疗。
Mol Cancer. 2023 Aug 18;22(1):138. doi: 10.1186/s12943-023-01827-6.
3
Milk Osteopontin and Human Health.牛奶骨桥蛋白与人类健康。
SPP1通过Nrf2/HO1途径减轻脑出血后铁死亡的能力。
Brain Behav. 2025 May;15(5):e70493. doi: 10.1002/brb3.70493.
4
Targeting the PI3K Pathway: Advancements and Achievements in Breast Cancer Therapy.靶向PI3K通路:乳腺癌治疗的进展与成果
Curr Pharm Des. 2025;31(31):2481-2503. doi: 10.2174/0113816128357976250122042633.
5
Characterization and evaluation of the cytotoxic, antioxidant, and anti-human lung cancer properties of copper nanoparticles green-synthesized by fennel extract following the PI3K/AKT/Mtor signaling pathway.通过茴香提取物绿色合成的铜纳米颗粒遵循PI3K/AKT/Mtor信号通路的细胞毒性、抗氧化和抗人肺癌特性的表征与评估。
PLoS One. 2025 Jan 9;20(1):e0309207. doi: 10.1371/journal.pone.0309207. eCollection 2025.
6
Double-Edged Sword Effect of Diet and Nutrition on Carcinogenic Molecular Pathways in Breast Cancer.饮食和营养对乳腺癌致癌分子途径的双刃剑效应。
Int J Mol Sci. 2024 Oct 15;25(20):11078. doi: 10.3390/ijms252011078.
Nutrients. 2023 May 23;15(11):2423. doi: 10.3390/nu15112423.
4
Anomanolide C suppresses tumor progression and metastasis by ubiquitinating GPX4-driven autophagy-dependent ferroptosis in triple negative breast cancer.阿那莫林 C 通过泛素化 GPX4 驱动的自噬依赖性铁死亡来抑制三阴性乳腺癌中的肿瘤进展和转移。
Int J Biol Sci. 2023 May 8;19(8):2531-2550. doi: 10.7150/ijbs.82120. eCollection 2023.
5
CD31 promotes diffuse large B-cell lymphoma metastasis by upregulating OPN through the AKT pathway and inhibiting CD8+ T cells through the mTOR pathway.CD31通过AKT途径上调骨桥蛋白并通过mTOR途径抑制CD8 + T细胞,从而促进弥漫性大B细胞淋巴瘤转移。
Am J Transl Res. 2023 Apr 15;15(4):2656-2675. eCollection 2023.
6
GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment.GPX4:脂质氧化、铁死亡、疾病和治疗的枢纽。
Biochim Biophys Acta Rev Cancer. 2023 May;1878(3):188890. doi: 10.1016/j.bbcan.2023.188890. Epub 2023 Mar 29.
7
LAG-3 expression in tumor microenvironment of triple-negative breast cancer.三阴性乳腺癌肿瘤微环境中的 LAG-3 表达。
Turk J Med Sci. 2023 Feb;53(1):142-148. doi: 10.55730/1300-0144.5567. Epub 2023 Feb 22.
8
Side-by-side comparison of recombinant human glutathione peroxidases identifies overlapping substrate specificities for soluble hydroperoxides.重组人谷胱甘肽过氧化物酶的并排比较确定了可溶性过氧化物的重叠底物特异性。
Redox Biol. 2023 Feb;59:102593. doi: 10.1016/j.redox.2022.102593. Epub 2023 Jan 2.
9
Ferroptosis and triple-negative breast cancer: Potential therapeutic targets.铁死亡与三阴性乳腺癌:潜在的治疗靶点。
Front Oncol. 2022 Dec 9;12:1017041. doi: 10.3389/fonc.2022.1017041. eCollection 2022.
10
Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells.Fin56 诱导的铁死亡受到自噬介导的 GPX4 降解的支持,并与 mTOR 抑制协同作用,杀死膀胱癌细胞。
Cell Death Dis. 2021 Oct 29;12(11):1028. doi: 10.1038/s41419-021-04306-2.